IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosisRossana G. Iannitti, Luigina Romani, Valerio Napolioni et al.|Nature Communications|2016Cited by 232
Biologics, theranostics, and personalized medicine in drug delivery systemsMatteo Puccetti, Maurizio Ricci, Marilena Pariano et al.|Pharmacological Research|2024Cited by 185
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metaboliteGiorgia Renga, Claudio Costantini, Emilia Nunzi et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 129
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosisSilvia Moretti, Luigina Romani, Rossana G. Iannitti et al.|Nature Communications|2017Cited by 129
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1RaMonica Borghi, Luigina Romani, Antonella De Luca et al.|Cell Host & Microbe|2015Cited by 106